VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $48,000 | -22.6% | 3,000 | 0.0% | 0.01% | -16.7% |
| Q4 2017 | $62,000 | +44.2% | 3,000 | 0.0% | 0.01% | +50.0% |
| Q3 2017 | $43,000 | -17.3% | 3,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $52,000 | +57.6% | 3,000 | 0.0% | 0.01% | +50.0% |
| Q1 2017 | $33,000 | -55.4% | 3,000 | 0.0% | 0.00% | -55.6% |
| Q4 2016 | $74,000 | 0.0% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $74,000 | +23.3% | 3,000 | 0.0% | 0.01% | +12.5% |
| Q2 2016 | $60,000 | -55.9% | 3,000 | +290.6% | 0.01% | -61.9% |
| Q3 2015 | $136,000 | -22.3% | 768 | -2.7% | 0.02% | -16.0% |
| Q2 2015 | $175,000 | -11.6% | 789 | -19.9% | 0.02% | -13.8% |
| Q1 2015 | $198,000 | +16.5% | 985 | -17.4% | 0.03% | +11.5% |
| Q4 2014 | $170,000 | -46.7% | 1,192 | -51.1% | 0.03% | -48.0% |
| Q3 2014 | $319,000 | +18.6% | 2,439 | +6.5% | 0.05% | +28.2% |
| Q2 2014 | $269,000 | +61.1% | 2,291 | +77.0% | 0.04% | +69.6% |
| Q1 2014 | $167,000 | +15.2% | 1,294 | +19.4% | 0.02% | +4.5% |
| Q4 2013 | $145,000 | +61.1% | 1,084 | +25.2% | 0.02% | +57.1% |
| Q3 2013 | $90,000 | +20.0% | 866 | -0.7% | 0.01% | -63.2% |
| Q2 2013 | $75,000 | +13.6% | 872 | -0.3% | 0.04% | +2.7% |
| Q1 2013 | $66,000 | -16.5% | 875 | -9.8% | 0.04% | -40.3% |
| Q2 2012 | $79,000 | +5.3% | 970 | +11.2% | 0.06% | 0.0% |
| Q1 2012 | $75,000 | – | 872 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |